1. BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models. (October 2022) Authors: Tavera, L.; Campbell, J.; Dhande, A.; Dineen, T.; Iliou, M.; Rouskin-Faust, T.; Rozsahegyi, E.; Conti, C. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗